Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 927

1.

[Molecular basis for negative-strand RNA virus entry and neutralization by antibodies].

Hashiguchi T.

Uirusu. 2017;67(1):69-78. doi: 10.2222/jsv.67.69. Review. Japanese.

2.

[Dynamics of the influenza virus genome regulated by cellular host factors].

Kawaguchi A.

Uirusu. 2017;67(1):59-68. doi: 10.2222/jsv.67.59. Review. Japanese.

3.

[Signal peptide peptidase participates in propagation and pathogenesis of hepatitis C virus].

Okamoto T.

Uirusu. 2017;67(1):49-58. doi: 10.2222/jsv.67.49. Japanese.

4.

[Emergence of emaraviruses, the eriophyoid mite-transmitted viruses in plants].

Kubota K.

Uirusu. 2017;67(1):37-48. doi: 10.2222/jsv.67.37. Japanese.

5.

[Countermeasures against Plum pox virus in Japan.]

Nakaune R.

Uirusu. 2017;67(1):35-36. doi: 10.2222/jsv.67.35. Japanese. No abstract available.

6.

[Social Responsibility of Virus Research].

Fujigaki Y.

Uirusu. 2017;67(1):33-34. doi: 10.2222/jsv.67.33. Japanese. No abstract available.

7.

[Measles Virus].

Tahara M, Takeda M.

Uirusu. 2017;67(1):3-16. doi: 10.2222/jsv.67.3. Review. Japanese.

8.

[Rodent associated hantaviruses and hantavirus infections].

Kariwa H.

Uirusu. 2017;67(1):25-32. doi: 10.2222/jsv.67.25. Japanese.

9.

[Current situation of measles in Japan, 2017].

Tanaka-Taya K.

Uirusu. 2017;67(1):17-24. doi: 10.2222/jsv.67.17. Review. Japanese.

10.

Neuropathogenesis of persistent infection with Borna disease virus.

Honda T.

Uirusu. 2015;65(1):145-54. doi: 10.2222/jsv.65.145. Review. Japanese.

11.

Investigation of Molecular Mechanism of JC virus Viroporin Activity.

Suzuki T.

Uirusu. 2015;65(1):135-44. doi: 10.2222/jsv.65.135. Review. Japanese.

12.

Innate recognition of influenza virus and vaccine development.

Ichinohe T.

Uirusu. 2015;65(1):127-34. doi: 10.2222/jsv.65.127. Review. Japanese.

13.

Disclosure and Submission of Potential Conflicts of Interest For the Japanese Society For Virology.

Shimizu H.

Uirusu. 2015;65(1):119-26. doi: 10.2222/jsv.65.119. Japanese. No abstract available.

14.

Domestic dengue epidemic in Japan, 2014.

Takasaki T.

Uirusu. 2015;65(1):115-8. doi: 10.2222/jsv.65.115. Japanese. No abstract available.

15.

Response to Ebola virus disease outbreak in West Africa by the Ministry of Health, Labour and Welfare of Japan in 2014-2015.

Saito T, Fukushima K, Abe K, Ujiie M, Umeki K, Ootsuka K, Matsumoto Y, Nabae K, Nakatani Y, Nakajima K.

Uirusu. 2015;65(1):105-14. doi: 10.2222/jsv.65.105. Japanese.

16.

Clinical Management of Patients with Ebola Virus Disease in Well-resourced Settings.

Kato Y.

Uirusu. 2015;65(1):95-104. doi: 10.2222/jsv.65.95. Review. Japanese.

17.

Preparedness for ebolavirus disease outbreak in Japan: Necessity of Biosafety level-4 facility.

Saijo M, Morita K.

Uirusu. 2015;65(1):89-94. doi: 10.2222/jsv.65.89. Review. Japanese.

18.

Non-biomedical factors in the Ebola virus disease outbreak in West Africa.

Adachi T.

Uirusu. 2015;65(1):83-8. doi: 10.2222/jsv.65.83. Japanese.

19.

Ebola virus host cell entry.

Sakurai Y.

Uirusu. 2015;65(1):71-82. doi: 10.2222/jsv.65.71. Review. Japanese.

20.

Ebola vaccine and treatment.

Takada A.

Uirusu. 2015;65(1):61-70. doi: 10.2222/jsv.65.61. Review. Japanese.

Supplemental Content

Loading ...
Support Center